Geode Capital Management’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Sell |
|
|||||
|
2025
Q1 | $133K | Buy |
|
|||||
|
2024
Q4 | $306K | Buy |
|
|||||
|
2024
Q3 | $941K | Buy |
|
|||||
|
2024
Q2 | $961K | Sell |
|
|||||
|
2024
Q1 | $2.64M | Buy |
|
|||||
|
2023
Q4 | $2.1M | Buy |
|
|||||
|
2023
Q3 | $1.83M | Buy |
|
|||||
|
2023
Q2 | $3.13M | Buy |
|
|||||
|
2023
Q1 | $1.57M | Buy |
|
|||||
|
2022
Q4 | $1.05M | Buy |
|
|||||
|
2022
Q3 | $1.6M | Buy |
|
|||||
|
2022
Q2 | $1.21M | Sell |
|
|||||
|
2022
Q1 | $4.07M | Buy |
|
|||||
|
2021
Q4 | $3.15M | Sell |
|
|||||
|
2021
Q3 | $4.33M | Buy |
|
|||||
|
2021
Q2 | $6.63M | Buy |
|
|||||
|
2021
Q1 | $1.52M | Buy |
|
|||||
|
2020
Q4 | $147K | Hold |
|
|||||
|
2020
Q3 | $150K | Buy |
|
|||||
|
2020
Q2 | $78K | Buy |
|